drugset / Trial / NCT02238717
Assessment of the Analgesic Effects of PF-06372865 in Healthy Volunteers Using Evoked Pain Endpoints
RandomizedCrossoverDouble-blindBasic science
Summary
This study will examine the activity of 2 different doses of PF-06372865 on a panel of evoked pain tests carried out from 0.5 to 10 hours following oral dosing in healthy male subjects.
Timeline
- Start
- 2014-09
- Primary completion
- 2014-11
- Completion
- 2014-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Darigabat | Small molecule | 15 mg | Oral |
| Subject | Darigabat | Small molecule | 65 mg | Oral |
| Comparator | Pregabalin | Small molecule | 300 mg | Oral |
Indications
No indication recorded.